Table of Content

1 INTRODUCTION (Page No. - 26)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED
    1.5 KEY STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 31)
    2.1 RESEARCH DATA
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Indicative list of secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET ESTIMATION METHODOLOGY
          FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
           2.2.2 USAGE-BASED MARKET ESTIMATION
                    FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL PCR  TECHNOLOGIES MARKET
           2.2.3 PRIMARY RESEARCH VALIDATION
    2.3 DATA TRIANGULATION
          FIGURE 5 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS
    2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 41)
    FIGURE 6 PCR TECHNOLOGIES MARKET, BY PRODUCT, 2021 VS. 2027 (USD MILLION)
    FIGURE 7 PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2021 VS. 2027 (USD MILLION)
    FIGURE 8 PCR TECHNOLOGIES MARKET, BY END USER, 2021 VS. 2027 (USD MILLION)
    FIGURE 9 GEOGRAPHICAL SNAPSHOT OF PCR TECHNOLOGIES MARKET

4 PREMIUM INSIGHTS (Page No. - 45)
    4.1 PCR TECHNOLOGIES MARKET OVERVIEW
          FIGURE 10 RISING INCIDENCE OF TARGET INFECTIOUS DISEASES AND GENETIC DISORDERS TO DRIVE MARKET GROWTH
    4.2 PCR TECHNOLOGIES MARKET SHARE, BY TECHNIQUE,  2021 VS. 2027
          FIGURE 11 REAL-TIME PCR SEGMENT ACCOUNTED FOR LARGEST SHARE OF PCR TECHNOLOGIES MARKET IN 2021
    4.3 PCR TECHNOLOGIES MARKET, BY APPLICATION,  2021 VS. 2027 (USD MILLION)
          FIGURE 12 DIAGNOSTIC APPLICATIONS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    4.4 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY END USER AND COUNTRY (2021)
          FIGURE 13 HOSPITALS AND DIAGNOSTIC CENTERS ARE LARGEST END-USERS OF PCR TECHNOLOGIES IN ASIA PACIFIC
    4.5 PCR TECHNOLOGIES MARKET, BY REGION
          FIGURE 14 ASIA PACIFIC MARKET TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD (2022–2027)

5 MARKET OVERVIEW (Page No. - 50)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 15 PCR TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,  AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising incidence of target infectious diseases and genetic disorders
                                FIGURE 16 GLOBAL BURDEN OF HIV INFECTIONS, BY REGION, 2021
                                FIGURE 17 GROWING GERIATRIC POPULATION ACROSS KEY GEOGRAPHIES,  2019 VS. 2050 (MILLION)
                    5.2.1.2 Continuous advancements in PCR technologies
                                TABLE 1 TRADITIONAL PCR VS. QPCR AND DPCR
                    5.2.1.3 Increasing investments, funds, and grants
                    5.2.1.4 Increasing use of biomarker profiling for disease diagnostics
                    5.2.1.5 Successful completion of Human Genome Project
           5.2.2 RESTRAINTS
                    5.2.2.1 High device costs associated with dPCR
                    5.2.2.2 Technical limitations of qPCR and dPCR
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing market penetration in emerging countries
                    5.2.3.2 Shift from plant-derived to genome-based drug discovery
           5.2.4 CHALLENGES
                    5.2.4.1 Adoption and implementation of MIQE guidelines
    5.3 TECHNOLOGY ANALYSIS
           5.3.1 DEVELOPMENT OF PORTABLE INSTRUMENTS USING PCR DIAGNOSTIC SERVICES
           5.3.2 DEVELOPMENT OF RAPID AND SENSITIVE DIAGNOSTIC KITS
    5.4 GLOBAL REGULATORY LANDSCAPE
           5.4.1 KEY REGULATORY AGENCIES
    5.5 VALUE CHAIN ANALYSIS
          FIGURE 18 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING REGULATION AND DISTRIBUTION STAGES
    5.6 SUPPLY CHAIN ANALYSIS
           5.6.1 PROMINENT COMPANIES
           5.6.2 SMALL & MEDIUM-SIZED ENTERPRISES
           5.6.3 END USERS
                    FIGURE 19 SUPPLY CHAIN ANALYSIS
    5.7 PRICING TREND ANALYSIS
          TABLE 2 AVERAGE PRICE OF PCR PRODUCTS, BY KEY PLAYER, 2021 (USD)
          FIGURE 20 AVERAGE PRICE OF DIFFERENT PCR ANALYZERS, BY TECHNOLOGY, 2021 (USD)
    5.8 REIMBURSEMENT SCENARIO
          TABLE 3 REIMBURSEMENT CODES FOR COVID-19 PCR TESTING IN US (AS OF 2022)
    5.9 ECOSYSTEM COVERAGE: PARENT MARKET
    5.10 PORTER’S FIVE FORCES ANALYSIS
           5.10.1 OVERVIEW
                     TABLE 4 PCR TECHNOLOGIES MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.10.2 DEGREE OF COMPETITION
           5.10.3 BARGAINING POWER OF SUPPLIERS
           5.10.4 BARGAINING POWER OF BUYERS
           5.10.5 THREAT OF NEW ENTRANTS
           5.10.6 THREAT OF SUBSTITUTES
    5.11 PATENT ANALYSIS
           FIGURE 21 NUMBER OF PATENTS FOR PCR TESTING
           FIGURE 22 NUMBER OF PATENTS FOR PCR DIAGNOSTICS
    5.12 TRADE ANALYSIS
           TABLE 5 IMPORT DATA FOR PCR ANALYZERS (HS CODE 3822), BY COUNTRY, 2017–2021 (USD)
           TABLE 6 EXPORT DATA FOR PCR ANALYZERS (HS CODE 3822), BY COUNTRY, 2017–2021 (USD)
    5.13 KEY CONFERENCES AND EVENTS (2022–2023)
           TABLE 7 PCR TECHNOLOGIES MARKET: LIST OF MAJOR CONFERENCES AND EVENTS
    5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
           5.14.1 DEVELOPMENT OF COMPACT, PORTABLE, AND LAB-ON-CHIP PCR DEVICES
           5.14.2 ONGOING TECHNOLOGICAL INTEGRATION WITH PCR PROCESS
    5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
           5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS, BY END USER
                     FIGURE 23 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS, BY END USER
                     TABLE 8 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS, BY END USER (%)
           5.15.2 BUYING CRITERIA
                     FIGURE 24 KEY BUYING CRITERIA, BY END USER
                     TABLE 9 KEY BUYING CRITERIA, BY END USER

6 PCR TECHNOLOGIES MARKET, BY PRODUCT (Page No. - 72)
    6.1 INTRODUCTION
          TABLE 10 PCR TECHNOLOGIES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 REAGENTS AND CONSUMABLES
           6.2.1 INCREASING NUMBER OF ANALYTICAL PROCEDURES AMONG RESEARCHERS TO FUEL MARKET GROWTH
                    TABLE 11 PCR REAGENTS AND CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.3 INSTRUMENTS
           6.3.1 INCREASING AVAILABILITY OF INNOVATIVE PCR INSTRUMENTS TO DRIVE MARKET GROWTH
                    TABLE 12 PCR INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.4 SOFTWARE AND SERVICES
           6.4.1 AUTOMATION AND DIGITALIZATION OF LABORATORY PROCESSES TO FUEL ADOPTION AMONG END USERS
                    TABLE 13 PCR SOFTWARE AND SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)

7 PCR TECHNOLOGIES MARKET, BY TECHNIQUE (Page No. - 77)
    7.1 INTRODUCTION
          TABLE 14 PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
    7.2 CONVENTIONAL PCR
           7.2.1 DIVERSE APPLICATIONS OF CONVENTIONAL PCR TO SUSTAIN MARKET GROWTH
                    TABLE 15 CONVENTIONAL PCR MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 16 CONVENTIONAL PCR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 17 CONVENTIONAL PCR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 18 CONVENTIONAL PCR MARKET, BY END USER, 2020–2027 (USD MILLION)
    7.3 REAL-TIME PCR
           7.3.1 GROWING ADOPTION AMONG RESEARCHERS AND HEALTHCARE PROFESSIONALS TO FUEL MARKET GROWTH
                    TABLE 19 REAL-TIME PCR MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 20 REAL-TIME PCR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 21 REAL-TIME PCR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 22 REAL-TIME PCR MARKET, BY END USER, 2020–2027 (USD MILLION)
    7.4 DIGITAL PCR
           7.4.1 ONGOING TECHNOLOGICAL DEVELOPMENTS WITH RESPECT TO DIGITAL PCR TO DRIVE MARKET GROWTH
                    TABLE 23 DIGITAL PCR MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 24 DIGITAL PCR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 25 DIGITAL PCR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 26 DIGITAL PCR MARKET, BY END USER, 2020–2027 (USD MILLION)
    7.5 REVERSE TRANSCRIPTION PCR
           7.5.1 HIGHER SENSITIVITY FOR MRNA DETECTION TO DRIVE MARKET GROWTH
                    TABLE 27 ONE-STEP RT-PCR VS. TWO-STEP RT-PCR
                    TABLE 28 REVERSE TRANSCRIPTION PCR MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 29 REVERSE TRANSCRIPTION PCR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 30 REVERSE TRANSCRIPTION PCR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 31 REVERSE TRANSCRIPTION PCR MARKET, BY END USER, 2020–2027 (USD MILLION)
    7.6 HOT-START PCR
           7.6.1 HASSLE-FREE SETUP OF SAMPLES KEY ADVANTAGE OFFERED  BY HOT-START PCR
                    TABLE 32 BENEFITS AND CONSIDERATIONS INVOLVED IN HOT-START TECHNOLOGY
                    TABLE 33 HOT-START PCR MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 34 HOT-START PCR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 35 HOT-START PCR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 36 HOT-START PCR MARKET, BY END USER, 2020–2027 (USD MILLION)
    7.7 MULTIPLEX PCR
           7.7.1 COST-EFFECTIVENESS OF THIS TECHNIQUE TO DRIVE MARKET GROWTH
                    TABLE 37 MULTIPLEX PCR MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 38 MULTIPLEX PCR MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 39 MULTIPLEX PCR MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 40 MULTIPLEX PCR MARKET, BY END USER, 2020–2027 (USD MILLION)
    7.8 OTHER PCR TECHNIQUES
          TABLE 41 OTHER PCR TECHNIQUES MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 42 OTHER PCR TECHNIQUES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 43 OTHER PCR TECHNIQUES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
          TABLE 44 OTHER PCR TECHNIQUES MARKET, BY END USER, 2020–2027 (USD MILLION)

8 PCR TECHNOLOGIES MARKET, BY APPLICATION (Page No. - 97)
    8.1 INTRODUCTION
          TABLE 45 PCR TECHNOLOGIES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    8.2 GENE EXPRESSION ANALYSIS
           8.2.1 GENE EXPRESSION ANALYSIS WIDELY USED IN EPIGENETICS, SIRNA QUANTIFICATION, MRNA ANALYSIS, AND CELL LINE VALIDATION
                    TABLE 46 PCR TECHNOLOGIES MARKET FOR GENE EXPRESSION ANALYSIS, BY REGION,  2020–2027 (USD MILLION)
    8.3 GENETIC SEQUENCING
           8.3.1 REDUCED COST OF SEQUENCING TO DRIVE MARKET GROWTH
                    TABLE 47 PCR TECHNOLOGIES MARKET FOR GENETIC SEQUENCING, BY REGION,  2020–2027 (USD MILLION)
    8.4 GENOTYPING
           8.4.1 SNP GENOTYPING CAN ACCELERATE PERSONALIZED MEDICINE DEVELOPMENT
                    TABLE 48 PCR TECHNOLOGIES MARKET FOR GENOTYPING, BY REGION,  2020–2027 (USD MILLION)
    8.5 NUCLEIC ACID DETECTION
           8.5.1 PCR TECHNIQUES HAVE WIDE APPLICATIONS IN NUCLEIC  ACID DETECTION
                    TABLE 49 PCR TECHNOLOGIES MARKET FOR NUCLEIC ACID DETECTION, BY REGION,  2020–2027 (USD MILLION)
    8.6 NUCLEIC ACID SYNTHESIS
           8.6.1 DNA SYNTHESIS HAS OPENED AVENUES FOR PROGRESS IN BIOLOGY
                    TABLE 50 PCR TECHNOLOGIES MARKET FOR NUCLEIC ACID SYNTHESIS, BY REGION,  2020–2027 (USD MILLION)
    8.7 STANDARD VALIDATION/VERIFICATION
           8.7.1 PCR TECHNIQUES USED FOR REGIONAL/GLOBAL VALIDATION  TO FRAME COMMERCIAL/NON-COMMERCIAL GUIDELINES
                    TABLE 51 PCR TECHNOLOGIES MARKET FOR STANDARD VALIDATION/VERIFICATION, BY REGION,  2020–2027 (USD MILLION)
    8.8 DIAGNOSTIC APPLICATIONS
           8.8.1 DIAGNOSTIC APPLICATIONS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE
                    TABLE 52 PCR TECHNOLOGIES MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION,  2020–2027 (USD MILLION)
    8.9 ENVIRONMENTAL APPLICATIONS
           8.9.1 PCR WIDELY USED TO DETECT PATHOGENS IN ENVIRONMENTAL SAMPLES
                    TABLE 53 PCR TECHNOLOGIES MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION,  2020–2027 (USD MILLION)
    8.10 OTHER APPLICATIONS
          TABLE 54 PCR TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY REGION,  2020–2027 (USD MILLION)

9 PCR TECHNOLOGIES MARKET, BY END USER (Page No. - 108)
    9.1 INTRODUCTION
          TABLE 55 PCR TECHNOLOGIES MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.2 HOSPITALS AND DIAGNOSTIC CENTERS
           9.2.1 HIGH PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH
                    TABLE 56 PCR TECHNOLOGIES MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2020–2027 (USD MILLION)
    9.3 HEALTHCARE INDUSTRY
           9.3.1 PCR HAS WIDE APPLICATIONS IN HEALTHCARE INDUSTRY
                    TABLE 57 PCR TECHNOLOGIES MARKET FOR HEALTHCARE INDUSTRY, BY REGION,  2020–2027 (USD MILLION)
    9.4 ACADEMIA AND GOVERNMENT ORGANIZATIONS
           9.4.1 AVAILABILITY OF COST-EFFECTIVE AND INNOVATIVE PCR PRODUCTS TO DRIVE ADOPTION
                    TABLE 58 PCR TECHNOLOGIES MARKET FOR ACADEMIA AND GOVERNMENT ORGANIZATIONS,  BY REGION, 2020–2027 (USD MILLION)
    9.5 PHARMA-BIOTECH COMPANIES
           9.5.1 INCREASING R&D INITIATIVES BY PHARMA-BIOTECH COMPANIES TO FUEL ADOPTION OF PCR TECHNOLOGIES
                    TABLE 59 PCR TECHNOLOGIES MARKET FOR PHARMA-BIOTECH COMPANIES,  BY REGION, 2020–2027 (USD MILLION)
    9.6 APPLIED INDUSTRIES
           9.6.1 INCREASING ENVIRONMENTAL REGULATIONS TO DRIVE ADOPTION OF PCR TECHNIQUES
                    TABLE 60 PCR TECHNOLOGIES MARKET FOR APPLIED INDUSTRIES, BY REGION,  2020–2027 (USD MILLION)
    9.7 OTHER END USERS
          TABLE 61 PCR TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION,  2020–2027 (USD MILLION)

10 PCR TECHNOLOGIES MARKET, BY REGION (Page No. - 116)
     10.1 INTRODUCTION
             TABLE 62 PCR TECHNOLOGIES MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.2 NORTH AMERICA
             FIGURE 25 NORTH AMERICA: PCR TECHNOLOGIES MARKET SNAPSHOT
             TABLE 63 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
             TABLE 64 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,  2020–2027 (USD MILLION)
             TABLE 65 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
             TABLE 66 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
             TABLE 67 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY END USER,  2020–2027 (USD MILLION)
             10.2.1 US
                        10.2.1.1 Growing adoption of PCR techniques in research and academia to drive market growth
                                      TABLE 68 US: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Government initiatives for supporting genomics research to propel growth
                                      TABLE 69 CANADA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
     10.3 EUROPE
             TABLE 70 EUROPE: PCR TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 71 EUROPE: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             TABLE 72 EUROPE: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 73 EUROPE: PCR TECHNOLOGIES MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 74 EUROPE: PCR TECHNOLOGIES MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Large-scale outsourcing of clinical diagnostic testing by hospitals to drive market growth
                                      TABLE 75 GERMANY: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Growing focus on genomics research to support market  growth
                                      TABLE 76 UK: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Initiatives for developing genomic medicine to support market growth
                                      TABLE 77 FRANCE: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Increasing R&D investments by pharmaceutical companies to propel market growth
                                      TABLE 78 ITALY: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Increasing prevalence of chronic and infectious diseases to drive market growth
                                      TABLE 79 SPAIN: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             10.3.6 REST OF EUROPE
                        TABLE 80 REST OF EUROPE: HIV AND TB INCIDENCE, BY COUNTRY, 2020
                        TABLE 81 REST OF EUROPE: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,  2020–2027 (USD MILLION)
     10.4 ASIA PACIFIC
             FIGURE 26 ASIA PACIFIC: PCR TECHNOLOGIES MARKET SNAPSHOT
             TABLE 82 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 83 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             TABLE 84 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 85 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
             TABLE 86 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.1 JAPAN
                        10.4.1.1 Strong research and healthcare infrastructure to support market growth
                                      TABLE 87 JAPAN: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Healthcare infrastructure modernization to support market growth
                                      TABLE 88 CHINA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Presence of large target patient population to support market growth
                                      TABLE 89 INDIA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             10.4.4 AUSTRALIA
                        10.4.4.1 High healthcare expenditure to drive demand for advanced healthcare technologies such as PCR
                                      TABLE 90 AUSTRALIA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             10.4.5 SOUTH KOREA
                        10.4.5.1 Growing number of private hospitals and independent testing laboratories to drive market growth
                                      TABLE 91 SOUTH KOREA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,  2020–2027 (USD MILLION)
             10.4.6 REST OF ASIA PACIFIC
                        TABLE 92 REST OF ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,  2020–2027 (USD MILLION)
     10.5 LATIN AMERICA
             TABLE 93 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 94 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,  2020–2027 (USD MILLION)
             TABLE 95 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 96 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
             TABLE 97 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY END USER,  2020–2027 (USD MILLION)
             10.5.1 BRAZIL
                        10.5.1.1 Brazil to dominate LATAM market during forecast period
                                      TABLE 98 BRAZIL: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             10.5.2 MEXICO
                        10.5.2.1 Favorable trade agreements to support imports and improve accessibility to PCR instruments
                                      TABLE 99 MEXICO: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
             10.5.3 REST OF LATIN AMERICA
                       TABLE 100 REST OF LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,  2020–2027 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
             10.6.1 LOW PURCHASING POWER OF END USERS AND INFRASTRUCTURAL LIMITATIONS TO RESTRAIN MARKET GROWTH
                        TABLE 101 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,  2020–2027 (USD MILLION)
                        TABLE 102 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                        TABLE 103 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                        TABLE 104 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY END USER,  2020–2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 154)
     11.1 INTRODUCTION
            FIGURE 27 KEY DEVELOPMENTS BY LEADING PLAYERS IN PCR TECHNOLOGIES MARKET, 2018–2022
     11.2 REVENUE SHARE ANALYSIS
            FIGURE 28 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN PCR TECHNOLOGIES MARKET
     11.3 MARKET SHARE ANALYSIS
            FIGURE 29 PCR TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2021
     11.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2021)
             11.4.1 STARS
             11.4.2 EMERGING LEADERS
             11.4.3 PERVASIVE PLAYERS
             11.4.4 PARTICIPANTS
                        FIGURE 30 PCR TECHNOLOGIES MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
     11.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (2021)
             11.5.1 PROGRESSIVE COMPANIES
             11.5.2 RESPONSIVE COMPANIES
             11.5.3 DYNAMIC COMPANIES
             11.5.4 STARTING BLOCKS
                        FIGURE 31 PCR TECHNOLOGIES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS (2021)
     11.6 COMPETITIVE SCENARIO
             11.6.1 PRODUCT LAUNCHES & APPROVALS
             11.6.2 DEALS
             11.6.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 164)
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
     12.1 KEY PLAYERS
             12.1.1 THERMO FISHER SCIENTIFIC, INC.
                        TABLE 105 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
                        FIGURE 32 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
             12.1.2 F. HOFFMANN-LA ROCHE LTD.
                        TABLE 106 ROCHE DIAGNOSTICS: BUSINESS OVERVIEW
                        FIGURE 33 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2021)
             12.1.3 BIO-RAD LABORATORIES, INC.
                        TABLE 107 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
                        FIGURE 34 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
             12.1.4 QIAGEN N.V.
                        TABLE 108 QIAGEN N.V.: BUSINESS OVERVIEW
                        FIGURE 35 QIAGEN N.V.: COMPANY SNAPSHOT (2021)
             12.1.5 TAKARA BIO, INC.
                        TABLE 109 TAKARA BIO, INC.: BUSINESS OVERVIEW
                        FIGURE 36 TAKARA BIO, INC.: COMPANY SNAPSHOT (2021)
             12.1.6 AGILENT TECHNOLOGIES, INC.
                        TABLE 110 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
                        FIGURE 37 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021)
             12.1.7 BIOMÉRIEUX S.A.
                        TABLE 111 BIOMÉRIEUX S.A.: BUSINESS OVERVIEW
                        FIGURE 38 BIOMÉRIEUX S.A.: COMPANY SNAPSHOT (2021)
             12.1.8 FLUIDIGM CORPORATION
                        TABLE 112 FLUIDIGM CORPORATION: BUSINESS OVERVIEW
                        FIGURE 39 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2021)
             12.1.9 DANAHER CORPORATION
                        TABLE 113 DANAHER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
             12.1.10 ABBOTT LABORATORIES
                        TABLE 114 ABBOTT LABORATORIES: BUSINESS OVERVIEW
                        FIGURE 41 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021)
             12.1.11 MERCK KGAA
                        TABLE 115 MERCK KGAA: BUSINESS OVERVIEW
                        FIGURE 42 MERCK KGAA: COMPANY SNAPSHOT (2021)
             12.1.12 BECTON, DICKINSON AND COMPANY
                        TABLE 116 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                        FIGURE 43 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
             12.1.13 PROMEGA CORPORATION
                        TABLE 117 PROMEGA CORPORATION: BUSINESS OVERVIEW
             12.1.14 EPPENDORF AG
                        TABLE 118 EPPENDORF AG: BUSINESS OVERVIEW
                        FIGURE 44 EPPENDORF AG: COMPANY SNAPSHOT (2021)
             12.1.15 ANALYTIK JENA AG (A WHOLLY OWNED SUBSIDIARY OF ENDRESS+HAUSER AG)
                        TABLE 119 ENDRESS+HAUSER: BUSINESS OVERVIEW
                        FIGURE 45 ENDRESS+HAUSER: COMPANY SNAPSHOT (2021)
     12.2 OTHER PLAYERS
             12.2.1 MERIDIAN BIOSCIENCE, INC.
             12.2.2 STILLA TECHNOLOGIES
             12.2.3 JN MEDSYS
             12.2.4 AVANCE BIOSCIENCES INC.
             12.2.5 LGC BIOSEARCH TECHNOLOGIES
             12.2.6 AZURA GENOMICS INC.
             12.2.7 BIONEER CORPORATION
             12.2.8 BLUE-RAY BIOTECH
             12.2.9 LUMINEX CORPORATION (A DIASORIN COMPANY)
             12.2.10 BIO MOLECULAR SYSTEMS
             12.2.11 AZURE BIOSYSTEMS
             12.2.12 CHAI INC.
             12.2.13 ENZO LIFE SCIENCES
             12.2.14 BIOMEME, INC.
             12.2.15 ELITECH GROUP SAS

*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 236)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 CUSTOMIZATION OPTIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS